PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti announced a class action lawsuit against PROCEPT BioRobotics, alleging securities fraud related to undisclosed inventory issues and a subsequent 18% stock drop. The complaint claims the company failed to disclose that handpiece sales materially exceeded procedures since early 2023, resulting in excess inventory and a significant revenue miss.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.